Abstract:Objective: Age-related macular degeneration (AMD), particularly its exudative form, is a primary cause of vision impairment in older adults. As diabetes becomes increasingly prevalent in aging, it is crucial to explore the potential relationship between diabetic retinopathy (DR) and AMD. This study aimed to assess the risk of developing overall, non-exudative, and exudative AMD in individuals with DR compared to those without retinopathy (non-DR) based on a nationwide population study in Taiwan. Methods: A retrospective cohort study was conducted using the Taiwan National Health Insurance Database (NHIRD) (2000–2013). A total of 3413 patients were placed in the study group (DR) and 13,652 in the control group (non-DR) for analysis. Kaplan–Meier analysis and the Cox proportional hazards model were used to calculate the hazard ratios (HRs) and adjusted hazard ratios (aHRs) for the development of AMD, adjusting for confounding factors, such as age, sex, and comorbid conditions. Results: Kaplan–Meier survival analysis indicated a significantly higher cumulative incidence of AMD in the DR group compared to the non-DR group (log-rank test, p < 0.001). Adjusted analyses revealed that individuals with DR faced a greater risk of overall AMD, with an aHR of 3.50 (95% CI = 3.10–3.95). For senile (unspecified) AMD, the aHR was 3.45 (95% CI = 3.04–3.92); for non-exudative senile AMD, it was 2.92 (95% CI = 2.08–4.09); and for exudative AMD, the aHR was 3.92 (95% CI = 2.51–6.14). Conclusion: DR is a significant risk factor for both overall, senile, exudative, and non-exudative AMD, even after adjusting for demographic and comorbid conditions. DR patients tend to have a higher prevalence of vascular comorbidities; however, our findings indicate that the ocular pathologies inherent to DR might have a more significant impact on the progression to AMD. Early detection and appropriate treatment of AMD is critically important among DR patients.

Aging and diabetic retinopathy: Inherently intertwined pathophysiological processes

Inflammatory Machenism in the Pathogenesis of Diabetic Retinopathy

Association between biological aging and diabetic retinopathy

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy

The pathophysiological mechanisms underlying diabetic retinopathy

Recent progress in early diagnosis and drug therapy for diabetic retinopathy

An overview of the pathogenesis of diabetic retinopathy

Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets

Advances in pathogenesis and treatment of diabetic macular edema

Advanced glycation end products in diabetic retinopathy and phytochemical therapy

Retinal Cell Damage in Diabetic Retinopathy

Genetic insights and emerging therapeutics in diabetic retinopathy: from molecular pathways to personalized medicine

Recent advances in the treatment and delivery system of diabetic retinopathy

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Glucose transport, transporters and metabolism in diabetic retinopathy

Molecules related to diabetic retinopathy in the vitreous and involved pathways

Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications

Protective or Harmful: The Dual Roles of Autophagy in Diabetic Retinopathy

Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

The Association between Diabetic Retinopathy and Macular Degeneration: A Nationwide Population-Based Study